Synchrony Financial (SYF) Could Be 20% Below Fair Value Following Vetspire Partnership

Synchrony Financial (SYF) drew fresh attention after CareCredit, its healthcare financing arm, agreed to embed payment options directly into Vetspire’s AI veterinary platform, linking consumer credit with real time pet care decisions. The recent Vetspire deal lands at a tricky moment for the stock, with the share price down 15.27% year to date and 8.11% over the past month. At the same time, Synchrony Financial’s 3-year total shareholder return of about 162% signals long-run momentum that...